{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T14:08:00Z","timestamp":1764684480108,"version":"3.46.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s11739-025-04102-2","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T10:47:35Z","timestamp":1756464455000},"page":"2307-2318","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fostering interconnected care in heart failure: a call to action for a comprehensive assessment and management of the patient\u2019s journey"],"prefix":"10.1007","volume":"20","author":[{"given":"Ignazio","family":"Cusmano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Loguercio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Di Salvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Gonella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Ambrosetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1070-8857","authenticated-orcid":false,"given":"Nuccia","family":"Morici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"issue":"1","key":"4102_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/ejhf.2333","volume":"24","author":"TA McDonagh","year":"2022","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M et al (2022) 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 24(1):4\u2013131. https:\/\/doi.org\/10.1002\/ejhf.2333","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"4102_CR2","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1002\/ejhf.2206","volume":"23","author":"GMC Rosano","year":"2021","unstructured":"Rosano GMC, Maura B, Metra M, B\u00f6hm M, Bauersachs J, Ben Gal T et al (2021) Patient profiling in heart failure for tailoring medical therapy. A consensus document of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 23(6):872\u2013881. https:\/\/doi.org\/10.1002\/ejhf.2206","journal-title":"Eur J Heart Fail"},{"issue":"19","key":"4102_CR3","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1016\/j.jacc.2019.03.464","volume":"73","author":"B Bozkurt","year":"2019","unstructured":"Bozkurt B (2019) Reasons for lack of improvement in treatment with evidence-based therapies in heart failure. J Am Coll Cardiol 73(19):2384\u20132387. https:\/\/doi.org\/10.1016\/j.jacc.2019.03.464","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"4102_CR4","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1002\/ejhf.1459","volume":"21","author":"M Komajda","year":"2019","unstructured":"Komajda M, Sch\u00f6pe J, Wagenpfeil S, Tavazzi L, B\u00f6hm M, Ponikowski P et al (2019) Physicians\u2019 guideline adherence is associated with long-term heart failure mortality in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry. Eur J Heart Fail 21(7):921\u2013929. https:\/\/doi.org\/10.1002\/ejhf.1459","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"4102_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jchf.2022.08.009","volume":"11","author":"G Savarese","year":"2023","unstructured":"Savarese G, Kishi T, Vardeny O, Adamsson Eyrd S, Bodeg\u00e5rd J, Lund LH et al (2023) Heart failure drug treatment\u2014Inertia, titration, and discontinuation. JACC Heart Fail 11(1):1\u201314. https:\/\/doi.org\/10.1016\/j.jchf.2022.08.009","journal-title":"JACC Heart Fail"},{"issue":"17","key":"4102_CR6","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1093\/eurheartj\/ehad118","volume":"44","author":"RS Taylor","year":"2023","unstructured":"Taylor RS, Dalal HM, Zwisler AD (2023) Cardiac rehabilitation for heart failure: \u2018Cinderella\u2019 or evidence-based pillar of care? Eur Heart J 44(17):1511\u20131518. https:\/\/doi.org\/10.1093\/eurheartj\/ehad118","journal-title":"Eur Heart J"},{"issue":"5","key":"4102_CR7","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1177\/2047487320913379","volume":"28","author":"M Ambrosetti","year":"2021","unstructured":"Ambrosetti M, Abreu A, Corr\u00e0 A, Hansen D, Frederix I, Iliou MC et al (2021) Secondary prevention through comprehensive cardiovascular rehabilitation: from knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology. Eur J Prev Cardiol 28(5):460\u2013495. https:\/\/doi.org\/10.1177\/2047487320913379","journal-title":"Eur J Prev Cardiol"},{"issue":"3","key":"4102_CR8","doi-asserted-by":"publisher","first-page":"CD003331","DOI":"10.1002\/14651858.CD003331.pub6","volume":"3","author":"C Molloy","year":"2024","unstructured":"Molloy C, Long L, Mordi IR, Bridges C, Sagar VA, Davies EJ et al (2024) Exercise-based cardiac rehabilitation for adults with heart failure. Cochrane Database Syst Rev 3(3):CD003331. https:\/\/doi.org\/10.1002\/14651858.CD003331.pub6","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"4102_CR9","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.jacc.2015.06.1089","volume":"66","author":"H Golwala","year":"2015","unstructured":"Golwala H, Pandey A, Ju C, Butler J, Yancy C, Bhatt DL et al (2015) Temporal trends and factors associated with cardiac rehabilitation referral among patients hospitalized with heart failure. J Am Coll Cardiol 66(8):917\u2013926. https:\/\/doi.org\/10.1016\/j.jacc.2015.06.1089","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"4102_CR10","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.mayocp.2016.10.014","volume":"92","author":"PA Ades","year":"2017","unstructured":"Ades PA, Keteyian SJ, Wright JS, Hamm LF, Lui K, Newlin K et al (2017) Increasing cardiac rehabilitation participation from 20% to 70%: a road map from the million hearts cardiac rehabilitation collaborative. Mayo Clin Proc 92(2):234\u2013242. https:\/\/doi.org\/10.1016\/j.mayocp.2016.10.014","journal-title":"Mayo Clin Proc"},{"issue":"12","key":"4102_CR11","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1002\/ejhf.3087","volume":"25","author":"LH Lund","year":"2023","unstructured":"Lund LH, Crespo-Leiro MG, Laroche C, Garcia-Pinilla JM, Bennis A, Vataman EB et al (2023) Rationale and design of the ESC heart failure III registry\u2014implementation and discovery. Eur J Heart Fail 25(12):2316\u20132330. https:\/\/doi.org\/10.1002\/ejhf.3087","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"4102_CR12","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1409077","volume":"371","author":"JJV McMurray","year":"2014","unstructured":"McMurray JJV, Packer M, Desai A, Gong J, Lefkowitz MP et al (2014) Angiotensin\u2013neprilysin inhibition versus enalapril in heart failure. N Engl J Med 371(11):993\u20131004. https:\/\/doi.org\/10.1056\/NEJMoa1409077","journal-title":"N Engl J Med"},{"issue":"8","key":"4102_CR13","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.cardfail.2021.03.012","volume":"27","author":"AP Carnicelli","year":"2021","unstructured":"Carnicelli AP, Lippman SJ, Greene SJ, Mentz RJ, Greiner MA, Hardy NC et al (2021) Sacubitril\/valsartan initiation and postdischarge adherence among patients hospitalized for heart failure. J Card Fail 27(8):826\u2013836. https:\/\/doi.org\/10.1016\/j.cardfail.2021.03.012","journal-title":"J Card Fail"},{"issue":"2","key":"4102_CR14","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s10741-018-9757-1","volume":"24","author":"AJ Sauer","year":"2019","unstructured":"Sauer AJ, Cole R, Jensen B, Pal J, Sharma N, Yehya A et al (2019) Practical guidance on the use of sacubitril\/valsartan for heart failure. Heart Fail Rev 24(2):167\u2013176. https:\/\/doi.org\/10.1007\/s10741-018-9757-1","journal-title":"Heart Fail Rev"},{"issue":"7","key":"4102_CR15","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1002\/ejhf.775","volume":"19","author":"S Paolillo","year":"2017","unstructured":"Paolillo S, Mapelli M, Bonomi A, Corr\u00e0 U, Piepoli M, Veglia F et al (2017) Prognostic role of \u03b2-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database. Eur J Heart Fail 19(7):904\u2013914. https:\/\/doi.org\/10.1002\/ejhf.775","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"4102_CR16","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.jchf.2015.03.008","volume":"3","author":"KW Prins","year":"2015","unstructured":"Prins KW, Neill JM, Tyler JO, Eckman PM, Duval S (2015) Effects of beta-blocker withdrawal in acute decompensated heart failure. JACC Heart Fail 3(8):647\u2013653. https:\/\/doi.org\/10.1016\/j.jchf.2015.03.008","journal-title":"JACC Heart Fail"},{"issue":"10","key":"4102_CR17","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A et al (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 341(10):709\u2013717. https:\/\/doi.org\/10.1056\/NEJM199909023411001","journal-title":"N Engl J Med"},{"issue":"14","key":"4102_CR18","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1056\/NEJMoa030207","volume":"348","author":"B Pitt","year":"2003","unstructured":"Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B et al (2003) Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348(14):1309\u20131321. https:\/\/doi.org\/10.1056\/NEJMoa030207","journal-title":"N Engl J Med"},{"issue":"21","key":"4102_CR19","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","volume":"381","author":"JJV McMurray","year":"2019","unstructured":"McMurray JJV, Solomon SD, Inzucchi SE, K\u00f8ber L, Kosiborod MN, Martinez FA et al (2019) Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med 381(21):1995\u20132008. https:\/\/doi.org\/10.1056\/NEJMoa1911303","journal-title":"N Engl J Med"},{"issue":"15","key":"4102_CR20","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","volume":"383","author":"M Packer","year":"2020","unstructured":"Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P et al (2020) Cardiovascular and renal outcomes with empagliflozin in heart failure. N Engl J Med 383(15):1413\u20131424. https:\/\/doi.org\/10.1056\/NEJMoa2022190","journal-title":"N Engl J Med"},{"issue":"16","key":"4102_CR21","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","volume":"385","author":"SD Anker","year":"2021","unstructured":"Anker SD, Butler J, Filippatos G, Ferreira JP, Bocchi E, B\u00f6hm M et al (2021) Empagliflozin in heart failure with a preserved ejection fraction. N Engl J Med 385(16):1451\u20131461. https:\/\/doi.org\/10.1056\/NEJMoa2107038","journal-title":"N Engl J Med"},{"issue":"12","key":"4102_CR22","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","volume":"387","author":"SD Solomon","year":"2022","unstructured":"Solomon SD, McMurray JJV, Claggett B, de Boer RA, DeMets D, Hernandez AF et al (2022) Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction. N Engl J Med 387(12):1089\u20131098. https:\/\/doi.org\/10.1056\/NEJMoa2206286","journal-title":"N Engl J Med"},{"issue":"15","key":"4102_CR23","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","volume":"383","author":"HJL Heerspink","year":"2020","unstructured":"Heerspink HJL, Stef\u00e1nsson BV, Correa-Rotter R, Chertow GM, Greene T, Hou FF et al (2020) Dapagliflozin in patients with chronic kidney disease. N Engl J Med 383(15):1436\u20131446. https:\/\/doi.org\/10.1056\/NEJMoa2024816","journal-title":"N Engl J Med"},{"issue":"9","key":"4102_CR24","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604. https:\/\/doi.org\/10.7326\/0003-4819-150-9-200905050-00006","journal-title":"Ann Intern Med"},{"issue":"22","key":"4102_CR25","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"B Zinman","year":"2015","unstructured":"Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S et al (2015) Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med 373(22):2117\u20132128. https:\/\/doi.org\/10.1056\/NEJMoa1504720","journal-title":"N Engl J Med"},{"issue":"3","key":"4102_CR26","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/s41591-021-01659-1","volume":"28","author":"AA Voors","year":"2022","unstructured":"Voors AA, Angermann CE, Teerlink JR, Collins SP, Kosiborod M, Biegus J et al (2022) The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial. Nat Med 28(3):568\u2013574. https:\/\/doi.org\/10.1038\/s41591-021-01659-1","journal-title":"Nat Med"},{"issue":"10","key":"4102_CR27","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.3390\/medicina60101583","volume":"60","author":"F Epelde","year":"2024","unstructured":"Epelde F (2024) Optimizing cardiac rehabilitation in heart failure: Comprehensive insights, barriers, and future strategies. Medicina (B Aires) 60(10):1583. https:\/\/doi.org\/10.3390\/medicina60101583","journal-title":"Medicina (B Aires)"},{"issue":"2","key":"4102_CR28","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1177\/2047487319893035","volume":"27","author":"MF Piepoli","year":"2020","unstructured":"Piepoli MF, Abreu A, Albus C, Ambrosetti M, Brotons C, Catapano AL et al (2020) Update on cardiovascular prevention in clinical practice: a position paper of the European Association of Preventive Cardiology of the European Society of Cardiology. Eur J Prev Cardiol 27(2):181\u2013205. https:\/\/doi.org\/10.1177\/2047487319893035","journal-title":"Eur J Prev Cardiol"},{"issue":"1","key":"4102_CR29","doi-asserted-by":"publisher","first-page":"e001949","DOI":"10.1136\/openhrt-2021-001949","volume":"9","author":"TK Tegegne","year":"2022","unstructured":"Tegegne TK, Rawstorn JC, Nourse RA, Kibret KT, Ahmed KY, Maddison R (2022) Effects of exercise-based cardiac rehabilitation delivery modes on exercise capacity and health-related quality of life in heart failure: a systematic review and network meta-analysis. Open Heart 9(1):e001949. https:\/\/doi.org\/10.1136\/openhrt-2021-001949","journal-title":"Open Heart"},{"issue":"14","key":"4102_CR30","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1001\/jama.2009.454","volume":"301","author":"CM O'Connor","year":"2009","unstructured":"O\u2019Connor CM, Whellan DJ, Lee KL, Keteyian SJ, Cooper LS, Ellis SJ et al (2009) Efficacy and safety of exercise training in patients with chronic heart failure. JAMA 301(14):1439. https:\/\/doi.org\/10.1001\/jama.2009.454","journal-title":"JAMA"},{"issue":"11","key":"4102_CR31","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1177\/2047487318815314","volume":"26","author":"NA Smart","year":"2019","unstructured":"Smart NA, Taylor R, Walker S, Warren F, Ciani O, Davos CH et al (2019) Exercise training for chronic heart failure (ExTraMATCH II): why all data are not equal. Eur J Prev Cardiol 26(11):1229\u20131231. https:\/\/doi.org\/10.1177\/2047487318815314","journal-title":"Eur J Prev Cardiol"},{"key":"4102_CR32","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.ijcard.2016.06.277","volume":"220","author":"NA Smart","year":"2016","unstructured":"Smart NA, Taylor R, Walker S, Warren F, Ciani O, Davos CH et al (2016) Telerehabilitation in heart failure patients: the evidence and the pitfalls. Int J Cardiol 220:408\u2013413. https:\/\/doi.org\/10.1016\/j.ijcard.2016.06.277","journal-title":"Int J Cardiol"},{"issue":"3","key":"4102_CR33","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3390\/ijerph21030339","volume":"21","author":"P Iyngkaran","year":"2024","unstructured":"Iyngkaran P, Appuhamilage PY, Patabandige G, Sarathchandra Peru Kandage PS, Usmani W, Hanna F (2024) Barriers to cardiac rehabilitation among patients diagnosed with cardiovascular diseases\u2014a scoping review. Int J Environ Res Public Health 21(3):339. https:\/\/doi.org\/10.3390\/ijerph21030339","journal-title":"Int J Environ Res Public Health"},{"key":"4102_CR34","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.123.010131","author":"M Husaini","year":"2023","unstructured":"Husaini M, Deych E, Waken RJ, Sells B, Lai A, Racette SB et al (2023) Intensive versus traditional cardiac rehabilitation: mortality and cardiovascular outcomes in a 2016\u20132020 retrospective medicare cohort. Circ Cardiovasc Qual Outcomes. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.123.010131","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"2","key":"4102_CR35","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.hfc.2021.01.007","volume":"17","author":"A Patti","year":"2021","unstructured":"Patti A, Merlo L, Ambrosetti M, Sarto P (2021) Exercise-based cardiac rehabilitation programs in heart failure patients. Heart Fail Clin 17(2):263\u2013271. https:\/\/doi.org\/10.1016\/j.hfc.2021.01.007","journal-title":"Heart Fail Clin"},{"issue":"1","key":"4102_CR36","doi-asserted-by":"publisher","first-page":"003331","DOI":"10.1002\/14651858.CD003331.pub6","volume":"1","author":"L Long","year":"2019","unstructured":"Long L, Mordi IR, Bridges C, Sagar VA, Davies EJ, Coats AJ et al (2019) Exercise-based cardiac rehabilitation for adults with heart failure. Cochrane Database Syst Rev 1(1):003331. https:\/\/doi.org\/10.1002\/14651858.CD003331.pub6","journal-title":"Cochrane Database Syst Rev"},{"issue":"25","key":"4102_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta23250","volume":"23","author":"RS Taylor","year":"2019","unstructured":"Taylor RS, Walker S, Ciani O, Warren F, Smart NA, Piepoli M et al (2019) Exercise-based cardiac rehabilitation for chronic heart failure: the EXTRAMATCH II individual participant data meta-analysis. Health Technol Assess 23(25):1\u201398. https:\/\/doi.org\/10.3310\/hta23250","journal-title":"Health Technol Assess"},{"issue":"8","key":"4102_CR38","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1002\/clc.23369","volume":"43","author":"A Kasiakogias","year":"2020","unstructured":"Kasiakogias A, Sharma S (2020) Exercise: the ultimate treatment to all ailments? Clin Cardiol 43(8):817\u2013826. https:\/\/doi.org\/10.1002\/clc.23369","journal-title":"Clin Cardiol"},{"issue":"18","key":"4102_CR39","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1161\/01.CIR.0000164270.72123.18","volume":"111","author":"JO O'Neill","year":"2005","unstructured":"O\u2019Neill JO, Young JB, Pothier CE, Lauer MS (2005) Peak oxygen consumption as a predictor of death in patients with heart failure receiving beta-blockers. Circulation 111(18):2313\u20132318. https:\/\/doi.org\/10.1161\/01.CIR.0000164270.72123.18","journal-title":"Circulation"},{"issue":"12","key":"4102_CR40","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1016\/j.jacc.2018.12.072","volume":"73","author":"RS Taylor","year":"2019","unstructured":"Taylor RS, Walker S, Smart NA et al (2019) Impact of exercise rehabilitation on exercise capacity and quality-of-life in heart failure: individual participant meta-analysis. J Am Coll Cardiol 73(12):1430\u20131443. https:\/\/doi.org\/10.1016\/j.jacc.2018.12.072","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"4102_CR41","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1007\/s10741-023-10310-9","volume":"28","author":"JL Taylor","year":"2023","unstructured":"Taylor JL, Myers J, Bonikowske AR (2023) Practical guidelines for exercise prescription in patients with chronic heart failure. Heart Fail Rev 28(6):1285\u20131296","journal-title":"Heart Fail Rev"},{"issue":"7","key":"4102_CR42","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1136\/heartjnl-2018-314206","volume":"105","author":"A Cowie","year":"2019","unstructured":"Cowie A, Buckley J, Doherty P, Furze G, Hayward J, Hinton S et al (2019) Standards and core components for cardiovascular disease prevention and rehabilitation. Heart 105(7):510\u2013515. https:\/\/doi.org\/10.1136\/heartjnl-2018-314206","journal-title":"Heart"},{"key":"4102_CR43","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1177\/2047487312460484","volume":"20","author":"A Mezzani","year":"2013","unstructured":"Mezzani A, Hamm LF, Jones AM, McBride PE, Moholdt T, Stone JA et al (2013) Aerobic exercise intensity assessment and prescription in cardiac rehabilitation: a joint position statement of the European Association for Cardiovascular Prevention and Rehabilitation, the American Association of Cardiovascular and Pulmonary Rehabilitat. Eur J Prev Cardiol 20:442\u2013467. https:\/\/doi.org\/10.1177\/2047487312460484","journal-title":"Eur J Prev Cardiol"},{"issue":"5","key":"4102_CR44","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.pcad.2020.08.004","volume":"63","author":"HE Billingsley","year":"2020","unstructured":"Billingsley HE, Hummel SL, Carbone S (2020) The role of diet and nutrition in heart failure: a state-of-the-art narrative review. Prog Cardiovasc Dis 63(5):538\u2013551. https:\/\/doi.org\/10.1016\/j.pcad.2020.08.004","journal-title":"Prog Cardiovasc Dis"},{"issue":"4","key":"4102_CR45","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/s0261-5614(03)00098-0","volume":"22","author":"J Kondrup","year":"2003","unstructured":"Kondrup J, Allison SP, Elia M, Vellas B, Plauth M, Educational and Clinical Practice Committee, European Society of Parenteral and Enteral Nutrition (ESPEN) (2003) ESPEN guidelines for nutrition screening. Clin Nutr 22(4):415\u2013421. https:\/\/doi.org\/10.1016\/s0261-5614(03)00098-0","journal-title":"Clin Nutr"},{"issue":"11","key":"4102_CR46","doi-asserted-by":"publisher","first-page":"100417","DOI":"10.1016\/j.cpcardiol.2019.03.006","volume":"45","author":"S Carbone","year":"2020","unstructured":"Carbone S, Billingsley HE, Rodriguez-Miguelez P, Kirkman DL, Garten R, Franco RL et al (2020) Lean mass abnormalities in heart failure: the role of sarcopenia, sarcopenic obesity, and cachexia. Curr Probl Cardiol 45(11):100417. https:\/\/doi.org\/10.1016\/j.cpcardiol.2019.03.006","journal-title":"Curr Probl Cardiol"},{"issue":"6","key":"4102_CR47","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.21037\/jtd-22-1865","volume":"15","author":"SI Lee","year":"2023","unstructured":"Lee SI, Choi CH, Park CH, Son KH (2023) Nutritional indices for screening sarcopenia before adult cardiac surgery. J Thorac Dis 15(6):3307\u20133318. https:\/\/doi.org\/10.21037\/jtd-22-1865","journal-title":"J Thorac Dis"},{"issue":"3","key":"4102_CR48","doi-asserted-by":"publisher","first-page":"830","DOI":"10.3945\/ajcn.115.113357","volume":"103","author":"M Rondanelli","year":"2016","unstructured":"Rondanelli M, Klersy C, Terracol G, Talluri J, Maugeri R, Guido D et al (2016) Whey protein, amino acids, and vitamin D supplementation with physical activity increases fat-free mass and strength, functionality, and quality of life and decreases inflammation in sarcopenic elderly. Am J Clin Nutr 103(3):830\u2013840. https:\/\/doi.org\/10.3945\/ajcn.115.113357","journal-title":"Am J Clin Nutr"},{"issue":"3 Suppl 1","key":"4102_CR49","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1053\/j.ajkd.2020.05.006","volume":"76","author":"TA Ikizler","year":"2020","unstructured":"Ikizler TA, Burrowes JD, Byham-Gray LD, Campbell KL, Carrero JJ, Chan W et al (2020) KDOQI clinical practice guideline for nutrition in CKD: 2020 update. Am J Kidney Dis 76(3 Suppl 1):S1\u2013S107","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"4102_CR50","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13098-023-01022-z","volume":"15","author":"ZJ Liu","year":"2023","unstructured":"Liu ZJ, Zhu CF (2023) Causal relationship between insulin resistance and sarcopenia. Diabetol Metab Syndr 15(1):46. https:\/\/doi.org\/10.1186\/s13098-023-01022-z","journal-title":"Diabetol Metab Syndr"},{"key":"4102_CR51","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.2147\/DMSO.S410834","volume":"16","author":"H Chen","year":"2023","unstructured":"Chen H, Huang X, Dong M, Wen S, Zhou L, Yuan X (2023) The association between sarcopenia and diabetes: from pathophysiology mechanism to therapeutic strategy. Diabetes Metab Syndr Obes 16:1541\u20131554. https:\/\/doi.org\/10.2147\/DMSO.S410834","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"1","key":"4102_CR52","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1186\/s12872-023-03500-8","volume":"23","author":"J Veskovic","year":"2023","unstructured":"Veskovic J, Cvetkovic M, Tahirovic E, Zdravkovic M, Apostolovic S, Kosevic D et al (2023) Depression, anxiety, and quality of life as predictors of rehospitalization in patients with chronic heart failure. BMC Cardiovasc Disord 23(1):525. https:\/\/doi.org\/10.1186\/s12872-023-03500-8","journal-title":"BMC Cardiovasc Disord"},{"issue":"4","key":"4102_CR53","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1348\/014466501163904","volume":"40","author":"JR Crawford","year":"2001","unstructured":"Crawford JR, Henry JD, Crombie C, Taylor EP (2001) Normative data for the HADS from a large non-clinical sample. Br J Clin Psychol 40(4):429\u2013434","journal-title":"Br J Clin Psychol"},{"issue":"20","key":"4102_CR54","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1016\/j.jacc.2020.09.542","volume":"76","author":"JA Spertus","year":"2020","unstructured":"Spertus JA, Jones PG, Sandhu AT, Arnold SV (2020) Interpreting the Kansas City cardiomyopathy questionnaire in clinical trials and clinical care: JACC state-of-the-art review. J Am Coll Cardiol 76(20):2379\u20132390. https:\/\/doi.org\/10.1016\/j.jacc.2020.09.542","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"4102_CR55","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2174\/1573403X12666160606122451","volume":"12","author":"SR Toukhsati","year":"2016","unstructured":"Toukhsati SR, Hare DL (2016) Towards optimal heart failure care: couples-oriented strategies to improve patient adherence and health outcomes. Curr Cardiol Rev 12(3):243\u2013248. https:\/\/doi.org\/10.2174\/1573403X12666160606122451","journal-title":"Curr Cardiol Rev"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-025-04102-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-025-04102-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-025-04102-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T14:03:01Z","timestamp":1764684181000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11739-025-04102-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":55,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["4102"],"URL":"https:\/\/doi.org\/10.1007\/s11739-025-04102-2","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"type":"print","value":"1828-0447"},{"type":"electronic","value":"1970-9366"}],"subject":[],"published":{"date-parts":[[2025,8,29]]},"assertion":[{"value":"28 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}